Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals faces mixed sentiment as positive trial data and strong sales are countered by regulatory concerns and negative social media buzz.

### About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on RNA interference (RNAi) therapeutics.  
Alnylam Pharmaceuticals, Inc. uses the ticker $ALNY for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Alnylam Pharmaceuticals, Inc. (ALNY) social dominance hit XXXXXX which is XXX% higher than it's daily average.
- Alnylam Pharmaceuticals, Inc. (ALNY) trading volume is up XXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. (ALNY) social dominance is up XXXXX% from the previous month.
- Alnylam Pharmaceuticals, Inc. (ALNY) engagements is up XXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. (ALNY) posts created is up XXXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. Price hit a 52-Week high of $XXX for the hour
- Alnylam Pharmaceuticals, Inc. Price hit an all time of $XXX for the hour

### Price: $XXXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/close.tsv)  
The stock price is experiencing volatility due to mixed news, with positive clinical trial data and strong sales being offset by regulatory concerns and negative social media sentiment, leading to a balanced outlook.  

24-Hour: -XXXX%
7-Day: -XXXX%
30-Day: -XXXX%

1-Year High: $XXXXXX on 2025-10-20  
1-Year Low: $XXXXXX on 2025-04-08  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/alt_rank.tsv)  
Alnylam Pharmaceuticals, Inc. (ALNY) is currently AltRank #539 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXX -XXX  
X Month: XXX -XX  
X Months: XXX +467  
X Year: XXX +78  
1-Year High: XXXXX on 2025-06-26  
1-Year Low: X on 2025-03-22  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX -XX  
X Month: XX -XX  
X Months: XX -XX  
X Year: XX no change  
1-Year High: XX on 2025-02-19  
1-Year Low: XX on 2025-06-26  
  
  
### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXXX  
X Week: XXXXXX +38%  
X Month: XXXXXXX -XX%  
X Months: XXXXXXXXX +12%  
X Year: XXXXXXXXX -XX%  
1-Year High: XXXXXXX on 2025-03-21  
1-Year Low: XXX on 2025-12-07  

Engagements by network (24h):
X: XXXXX

  
  
### Mentions: XXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/posts_active.tsv)  
Current Value: XXX  
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXX -XXXX%  
X Months: XXXXX +21%  
X Year: XXXXX -XX%  
1-Year High: XXX on 2025-08-13  
1-Year Low: XX on 2025-12-07  

Mentions by network (24h):
X: XXX

  
  
### Creators: XXX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Alnylam Pharmaceuticals, Inc. (ALNY) in the last XX hours which is up XXX% from XX in the previous XX hours
Daily Average: XXX  
X Week: XXX -XXXX%  
X Month: XXX -XXXX%  
X Months: XXXXX +104%  
X Year: XXXXX +58%  
1-Year High: XXX on 2025-06-28  
1-Year Low: XX on 2025-12-07  

The most influential creators that mention Alnylam Pharmaceuticals, Inc. in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | X    | XXXXX     | X     | XXX         |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)         | X    | XXXXXX    | X     | XXX         |
| [@ElsaPhe22932079](/creator/twitter/ElsaPhe22932079) | X    | XXX       | X     | XXX         |
| [@RosaJim94865433](/creator/twitter/RosaJim94865433) | X    | XXX       | X     | XXX         |
| [@GeneInvesting](/creator/twitter/GeneInvesting)     | X    | XXXXXX    | X     | XXX         |
| [@FrenzyCapital](/creator/twitter/FrenzyCapital)     | X    | XXXXX     | X     | XXX         |
| [@mondall34469](/creator/twitter/mondall34469)       | X    | XX        | X     | XXX         |
| [@neonaveed](/creator/twitter/neonaveed)             | X    | XXX       | X     | XXX         |
| [@FNicolasFloyd](/creator/twitter/FNicolasFloyd)     | X    | XXX       | X     | XX          |
| [@paulBIOgeek](/creator/twitter/paulBIOgeek)         | XX   | XXX       | X     | XX          |

[View More](/list/creators/alnylam-pharmaceuticals-inc/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XX% -XX%  
X Months: XX% -XX%  
X Year: XX% -XX%  
1-Year High: XXX% on 2025-07-29  
1-Year Low: XX% on 2025-12-02  

Most Supportive Themes:
- Positive Data from HELIOS-B Study: (35%) New data from the HELIOS-B Phase X study shows reduced gastrointestinal events in ATTR-CM patients treated with Vutrisiran, supporting its use as a first-line therapy.
- Amvuttra Sales and Revenue Guidance: (20%) Alnylam reported strong Amvuttra sales and increased its 2025 revenue guidance, indicating positive financial performance.
- First Patient Dosed in ZENITH Trial: (15%) Alnylam announced the first patient has been dosed in the ZENITH Global Phase X cardiovascular outcomes trial of Zilebesiran, marking progress in its clinical pipeline.
  
Most Critical Themes:
- Negative Sentiment on X: (20%) A significant portion of posts on X express negative sentiment, with users raising concerns about the company.
- FDA Crackdown and Ad Pull: (10%) Alnylam has withdrawn TV advertisements following regulatory action on drug industry advertising, which may lead to concerns.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXXX%  
X Week: XXXXX% +0.0064%  
X Month: XXXXX% +0.057%  
X Months: XXXXX% +0.049%  
X Year: XXXXX% -XXXXXX%  
1-Year High: XXXXX% on 2025-01-23  
1-Year Low: XXXXXX% on 2025-12-07  
  
  
### Market Dominance: XXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/market_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-09-09  
1-Year Low: XXXXX% on 2025-01-06  
  
  
### Market Cap: $XXXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXXX -$11%  
X Month: $XXXXXXXXXXXXXX -$6.20%  
X Months: $XXXXXXXXXXXXXX +$38%  
X Year: $XXXXXXXXXXXXXX +$66%  
1-Year High: $XXXXXXXXXXXXXX on 2025-10-20  
1-Year Low: $XXXXXXXXXXXXXX on 2025-04-08  

### Top Alnylam Pharmaceuticals, Inc. Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"9/10 Thats why $ARWR is totally miscomped. The right peers are $ALNY and $IONS platforms that repeatedly generate drugs and earn higher multiples"  
[X Link](https://x.com/BioBoyScout/status/1998463023363600721) [@BioBoyScout](/creator/x/BioBoyScout) 2025-12-09T18:41Z 4011 followers, XXX engagements


"$ALNY 🙋♂ Guys Don't miss the next move in a few hours. :-"  
[X Link](https://x.com/mondall34469/status/1998401985981071777) [@mondall34469](/creator/x/mondall34469) 2025-12-09T14:38Z XX followers, XX engagements


"$ALNY new alerts have been posted in the last hours-"  
[X Link](https://x.com/AnitaMc26910087/status/1998400826260488371) [@AnitaMc26910087](/creator/x/AnitaMc26910087) 2025-12-09T14:34Z XXX followers, XX engagements


"Buy the Dip Signals for XX Dec 2025 $AIRS at XXXX $ALNY at XXXXX $AMPY at XXXX $BWIN at XXXXX $BYND at XXXX $DGNX at XXXX $HLLY at XXXX $HOV at XXXXX $NAIL at XXXX $NFLU at XXXXX $NFXL at XXXXX $SNWV at 27.45"  
[X Link](https://x.com/forcewalke81743/status/1998339424958951852) [@forcewalke81743](/creator/x/forcewalke81743) 2025-12-09T10:30Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals faces mixed sentiment as positive trial data and strong sales are countered by regulatory concerns and negative social media buzz.

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on RNA interference (RNAi) therapeutics.
Alnylam Pharmaceuticals, Inc. uses the ticker $ALNY for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Alnylam Pharmaceuticals, Inc. (ALNY) social dominance hit XXXXXX which is XXX% higher than it's daily average.
  • Alnylam Pharmaceuticals, Inc. (ALNY) trading volume is up XXXXX% from the previous week.
  • Alnylam Pharmaceuticals, Inc. (ALNY) social dominance is up XXXXX% from the previous month.
  • Alnylam Pharmaceuticals, Inc. (ALNY) engagements is up XXXXX% from the previous week.
  • Alnylam Pharmaceuticals, Inc. (ALNY) posts created is up XXXXXX% from the previous week.
  • Alnylam Pharmaceuticals, Inc. Price hit a 52-Week high of $XXX for the hour
  • Alnylam Pharmaceuticals, Inc. Price hit an all time of $XXX for the hour

Price: $XXXXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price is experiencing volatility due to mixed news, with positive clinical trial data and strong sales being offset by regulatory concerns and negative social media sentiment, leading to a balanced outlook.

24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: -XXXX%

1-Year High: $XXXXXX on 2025-10-20
1-Year Low: $XXXXXX on 2025-04-08

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Alnylam Pharmaceuticals, Inc. (ALNY) is currently AltRank #539 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX -XXX
X Month: XXX -XX
X Months: XXX +467
X Year: XXX +78
1-Year High: XXXXX on 2025-06-26
1-Year Low: X on 2025-03-22

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX -XX
X Year: XX no change
1-Year High: XX on 2025-02-19
1-Year Low: XX on 2025-06-26

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX +38%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +12%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-03-21
1-Year Low: XXX on 2025-12-07

Engagements by network (24h): X: XXXXX

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXX -XXXX%
X Months: XXXXX +21%
X Year: XXXXX -XX%
1-Year High: XXX on 2025-08-13
1-Year Low: XX on 2025-12-07

Mentions by network (24h): X: XXX

Creators: XXX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Alnylam Pharmaceuticals, Inc. (ALNY) in the last XX hours which is up XXX% from XX in the previous XX hours Daily Average: XXX
X Week: XXX -XXXX%
X Month: XXX -XXXX%
X Months: XXXXX +104%
X Year: XXXXX +58%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-12-07

The most influential creators that mention Alnylam Pharmaceuticals, Inc. in the last XX hours

Creator Rank Followers Posts Engagements
@Andre_AGTC X XXXXX X XXX
@RNAiAnalyst X XXXXXX X XXX
@ElsaPhe22932079 X XXX X XXX
@RosaJim94865433 X XXX X XXX
@GeneInvesting X XXXXXX X XXX
@FrenzyCapital X XXXXX X XXX
@mondall34469 X XX X XXX
@neonaveed X XXX X XXX
@FNicolasFloyd X XXX X XX
@paulBIOgeek XX XXX X XX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-07-29
1-Year Low: XX% on 2025-12-02

Most Supportive Themes:

  • Positive Data from HELIOS-B Study: (35%) New data from the HELIOS-B Phase X study shows reduced gastrointestinal events in ATTR-CM patients treated with Vutrisiran, supporting its use as a first-line therapy.
  • Amvuttra Sales and Revenue Guidance: (20%) Alnylam reported strong Amvuttra sales and increased its 2025 revenue guidance, indicating positive financial performance.
  • First Patient Dosed in ZENITH Trial: (15%) Alnylam announced the first patient has been dosed in the ZENITH Global Phase X cardiovascular outcomes trial of Zilebesiran, marking progress in its clinical pipeline.

Most Critical Themes:

  • Negative Sentiment on X: (20%) A significant portion of posts on X express negative sentiment, with users raising concerns about the company.
  • FDA Crackdown and Ad Pull: (10%) Alnylam has withdrawn TV advertisements following regulatory action on drug industry advertising, which may lead to concerns.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.0064%
X Month: XXXXX% +0.057%
X Months: XXXXX% +0.049%
X Year: XXXXX% -XXXXXX%
1-Year High: XXXXX% on 2025-01-23
1-Year Low: XXXXXX% on 2025-12-07

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-09-09
1-Year Low: XXXXX% on 2025-01-06

Market Cap: $XXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX -$11%
X Month: $XXXXXXXXXXXXXX -$6.20%
X Months: $XXXXXXXXXXXXXX +$38%
X Year: $XXXXXXXXXXXXXX +$66%
1-Year High: $XXXXXXXXXXXXXX on 2025-10-20
1-Year Low: $XXXXXXXXXXXXXX on 2025-04-08

Top Alnylam Pharmaceuticals, Inc. Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"9/10 Thats why $ARWR is totally miscomped. The right peers are $ALNY and $IONS platforms that repeatedly generate drugs and earn higher multiples"
X Link @BioBoyScout 2025-12-09T18:41Z 4011 followers, XXX engagements

"$ALNY 🙋♂ Guys Don't miss the next move in a few hours. :-"
X Link @mondall34469 2025-12-09T14:38Z XX followers, XX engagements

"$ALNY new alerts have been posted in the last hours-"
X Link @AnitaMc26910087 2025-12-09T14:34Z XXX followers, XX engagements

"Buy the Dip Signals for XX Dec 2025 $AIRS at XXXX $ALNY at XXXXX $AMPY at XXXX $BWIN at XXXXX $BYND at XXXX $DGNX at XXXX $HLLY at XXXX $HOV at XXXXX $NAIL at XXXX $NFLU at XXXXX $NFXL at XXXXX $SNWV at 27.45"
X Link @forcewalke81743 2025-12-09T10:30Z XXX followers, XXX engagements

Alnylam Pharmaceuticals, Inc. (ALNY)
/topic/$alny